Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;75(12):3069-3076.
doi: 10.1111/all.14586. Epub 2020 Sep 22.

Advances and novel developments in allergic rhinitis

Yifan Meng  1   2 , Chengshuo Wang  1   2 , Luo Zhang  1   2   3   4
Affiliations
Review

Advances and novel developments in allergic rhinitis

Yifan Meng et al. Allergy. 2020 Dec.

Abstract

Allergic rhinitis (AR) is an upper airway disease with high prevalence in the world, and therefore needs to be thoroughly investigated and treated accordingly. Although the mechanisms underlying the pathology and treatment of AR have been widely studied, many aspects of AR are still unclear and warrant further investigations. The purpose of the present review was therefore to report recently published papers, which highlight the novel mechanisms and treatments of AR. These include role of environment, important proteins and cells, and some other factors in the pathogenesis of AR; as well as the role of immunotherapy and biologics in the treatment of AR.

Keywords: allergic rhinitis; biologics; mechanisms; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140:950-958.
    1. Eguiluz-Gracia I, Fernandez-Santamaria R, Testera-Montes A, et al. Coexistence of nasal reactivity to allergens with and without IgE-sensitization in patients with allergic rhinitis. Allergy. 2020;75:1689-1698.
    1. Leth-Møller KB, Skaaby T, Linneberg A. Allergic rhinitis and allergic sensitisation are still increasing among Danish adults. Allergy. 2020;75:660-668.
    1. Matsumoto K, Kouzaki H, Yamamoto S, et al. In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen. Allergy. 2020;75:446-449.
    1. Urashima M, Asaka D, Endo T, et al. Japanese cedar pollinosis in Tokyo residents born after massive national afforestation policy. Allergy. 2018;73:2395-2397.

Publication types

LinkOut - more resources